COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 234.0 | 6 | 0042-0568 | 321.68 | 568.31 | 295 | 65.60 | 0.861 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 203.8 | 6 | 0043-0582 | 382.57 | 582.43 | 275 | 67.70 | 0.754 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 249.0 | 6 | 0044-0604 | 753.16 | 604.08 | 233 | 58.53 | 0.855 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 316.4 | 6 | 0045-0611 | 859.18 | 611.21 | 210 | 59.36 | 0.749 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 257.1 | 6 | 0046-0612 | 890.31 | 612.54 | 187 | 57.94 | 0.700 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 323.1 | 6 | 0047-0614 | 613.01 | 614.72 | 215 | 56.87 | 0.835 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 215.9 | 6 | 0048-0640 | 352.25 | 639.51 | 291 | 66.43 | 0.829 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 306.3 | 6 | 0049-0646 | 575.91 | 645.49 | 232 | 59.60 | 0.821 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 285.1 | 6 | 0050-0650 | 617.75 | 651.14 | 208 | 57.84 | 0.781 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 245.2 | 6 | 0051-0653 | 123.89 | 653.61 | 205 | 60.53 | 0.703 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 279.6 | 6 | 0052-0677 | 466.12 | 677.74 | 244 | 59.94 | 0.853 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 240.8 | 6 | 0053-0686 | 593.53 | 685.73 | 205 | 59.94 | 0.717 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 262.1 | 6 | 0054-0691 | 513.60 | 691.38 | 248 | 61.60 | 0.821 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 196.9 | 6 | 0055-0700 | 351.11 | 699.46 | 279 | 62.53 | 0.897 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 224.8 | 6 | 0056-0709 | 218.08 | 709.28 | 259 | 60.77 | 0.881 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 330.7 | 6 | 0057-0709 | 832.68 | 709.43 | 206 | 58.28 | 0.762 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 328.4 | 7 | 0001-0053 | 156.06 | 53.48 | 189 | 52.87 | 0.850 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 271.7 | 7 | 0002-0055 | 530.23 | 55.22 | 234 | 56.87 | 0.909 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 220.9 | 7 | 0003-0059 | 856.52 | 59.19 | 222 | 59.46 | 0.789 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 284.6 | 7 | 0004-0066 | 818.80 | 66.19 | 139 | 61.60 | 0.460 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 287.9 | 7 | 0005-0108 | 391.66 | 108.22 | 211 | 60.04 | 0.736 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 231.9 | 7 | 0006-0106 | 876.52 | 106.30 | 260 | 62.77 | 0.829 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 350.7 | 7 | 0007-0126 | 468.55 | 126.58 | 207 | 53.11 | 0.922 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 290.3 | 7 | 0008-0146 | 857.50 | 145.91 | 227 | 61.60 | 0.752 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 338.2 | 7 | 0009-0151 | 424.38 | 151.78 | 184 | 51.46 | 0.873 |